Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein.

Costin JM, Rausch JM, Garry RF, Wimley WC.

Virol J. 2007 Nov 20;4:123.

3.

The cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein gp41 harbors lipid raft association determinants.

Yang P, Ai LS, Huang SC, Li HF, Chan WE, Chang CW, Ko CY, Chen SS.

J Virol. 2010 Jan;84(1):59-75. doi: 10.1128/JVI.00899-09. Epub .

6.

A synthetic peptide corresponding to the carboxy terminus of human immunodeficiency virus type 1 transmembrane glycoprotein induces alterations in the ionic permeability of Xenopus laevis oocytes.

Comardelle AM, Norris CH, Plymale DR, Gatti PJ, Choi B, Fermin CD, Haislip AM, Tencza SB, Mietzner TA, Montelaro RC, Garry RF.

AIDS Res Hum Retroviruses. 1997 Nov 20;13(17):1525-32. Review.

PMID:
9390752
7.
8.

HIV-1 Cell-Free and Cell-to-Cell Infections Are Differentially Regulated by Distinct Determinants in the Env gp41 Cytoplasmic Tail.

Durham ND, Chen BK.

J Virol. 2015 Sep;89(18):9324-37. doi: 10.1128/JVI.00655-15. Epub 2015 Jul 1.

9.

Unique functional properties of conserved arginine residues in the lentivirus lytic peptide domains of the C-terminal tail of HIV-1 gp41.

Kuhlmann AS, Steckbeck JD, Sturgeon TJ, Craigo JK, Montelaro RC.

J Biol Chem. 2014 Mar 14;289(11):7630-40. doi: 10.1074/jbc.M113.529339. Epub 2014 Feb 4.

10.

Protective effect of glutathione in HIV-1 lytic peptide 1-induced cell death in human neuronal cells.

Sung JH, Shin SA, Park HK, Montelaro RC, Chong YH.

J Neurovirol. 2001 Oct;7(5):454-65.

PMID:
11582518
11.

Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein.

Miller MA, Cloyd MW, Liebmann J, Rinaldo CR Jr, Islam KR, Wang SZ, Mietzner TA, Montelaro RC.

Virology. 1993 Sep;196(1):89-100.

PMID:
8356808
12.

Design and evaluation of antiretroviral peptides corresponding to the C-terminal heptad repeat region (C-HR) of human immunodeficiency virus type 1 envelope glycoprotein gp41.

Soonthornsata B, Tian YS, Utachee P, Sapsutthipas S, Isarangkura-na-Ayuthaya P, Auwanit W, Takagi T, Ikuta K, Sawanpanyalert P, Kawashita N, Kameoka M.

Virology. 2010 Sep 15;405(1):157-64. doi: 10.1016/j.virol.2010.06.012. Epub 2010 Jul 2.

14.

Peptide and non-peptide HIV fusion inhibitors.

Jiang S, Zhao Q, Debnath AK.

Curr Pharm Des. 2002;8(8):563-80. Review.

PMID:
11945159
15.

HIV gp41 C-terminal heptad repeat contains multifunctional domains. Relation to mechanisms of action of anti-HIV peptides.

Liu S, Jing W, Cheung B, Lu H, Sun J, Yan X, Niu J, Farmar J, Wu S, Jiang S.

J Biol Chem. 2007 Mar 30;282(13):9612-20. Epub 2007 Feb 2.

16.

Highly conserved structural properties of the C-terminal tail of HIV-1 gp41 protein despite substantial sequence variation among diverse clades: implications for functions in viral replication.

Steckbeck JD, Craigo JK, Barnes CO, Montelaro RC.

J Biol Chem. 2011 Aug 5;286(31):27156-66. doi: 10.1074/jbc.M111.258855. Epub 2011 Jun 9.

17.

Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.

Dimitrov AS, Rawat SS, Jiang S, Blumenthal R.

Biochemistry. 2003 Dec 9;42(48):14150-8.

PMID:
14640682
19.

Cytopathic mechanisms of HIV-1.

Costin JM.

Virol J. 2007 Oct 18;4:100. Review.

20.

Interruption of T-cell signal transduction by lentivirus lytic peptides from HIV-1 transmembrane protein.

Beary TP, Tencza SB, Mietzner TA, Montelaro RC.

J Pept Res. 1998 Jan;51(1):75-9.

PMID:
9495594
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk